Delhi High Court says payments to overseas units aren't automatically taxable in India
The dispute involved payments made by Ranbaxy, now merged with Sun Pharmaceutical Industries Ltd, to Teva Israel under a 2011 settlement relating to the US launch of generic atorvastatin.
The Delhi High Court has determined that payments made by Indian companies to foreign entities are not automatically subject to taxation within India. This ruling pertains to a case involving Israeli pharmaceutical company Teva and the now-defunct Ranbaxy Laboratories. Reporter Krishna Yadav of Mint, based in New Delhi, covers legal and regulatory developments affecting corporate India, including taxation issues.
Written by urgent.news from Live Mint's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
Also reported by 1 other outlet
- 'India’s ‘sugar high’ warrants caution on RBI hikes' economictimes.indiatimes.com
